[Long-terme outcome of peritoneal dialysis treatment--27 years of single centre experience].

Q4 Medicine Acta Medica Croatica Pub Date : 2008-01-01
Nikola Janković, Nikola Perković
{"title":"[Long-terme outcome of peritoneal dialysis treatment--27 years of single centre experience].","authors":"Nikola Janković,&nbsp;Nikola Perković","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>By the end of 2007 we had 160 patients on CAPD treatment in our centre (44% male, 56% female) aged between 29-78 years. Till 1994 13% of our patients were diabetics. In the last 10 years (1997-2007) the percentage of diabetics increased to 36%. During the 27 years period 44% of our patients died, 35% switched to haemodialysis and 3% have undergone renal transplantation. The survival rate after three years of treatment was 75%, after five years 63% and after 10 years 44%. Technique survival was 77%, 65% and 48% respectively. There were 309 episodes of peritonitis as the main complication of treatment (one episode on every 9, 4 months of treatment till 1994 and one episode on every 25, 8 months in the last ten years), out of which 58% was caused by Gram positive bacteria, 18% by Gram negative, 4% were fungal infections while the remaining 20% were culture negative. Regarding other complications we had 42 exit-site infections and 8 episodes of sclerosing peritonitis with 4 deaths. We found peritonitis to be the main reason of switching to haemodialysis (71%) and the main reason of death (39%) among the patients on CAPD. In the last 10 years (1997-2007) we analyzed the diabetics group separately and we found that the rate of CAPD dropout was not significantly different between diabetics and non-diabetics group. However, when analysing the causes of CAPD dropout, we found significant difference in mortality ate (50% among diabetics versus 26% among non-diabetics) and the rate of switching to haemodialysis (37% versus 55% respectively). In addition we established that the rate of CAPD survival was better after 1994 and we speculate that the main reason is the diminished peritonitis rate.</p>","PeriodicalId":35756,"journal":{"name":"Acta Medica Croatica","volume":" ","pages":"17-20"},"PeriodicalIF":0.0000,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Medica Croatica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

By the end of 2007 we had 160 patients on CAPD treatment in our centre (44% male, 56% female) aged between 29-78 years. Till 1994 13% of our patients were diabetics. In the last 10 years (1997-2007) the percentage of diabetics increased to 36%. During the 27 years period 44% of our patients died, 35% switched to haemodialysis and 3% have undergone renal transplantation. The survival rate after three years of treatment was 75%, after five years 63% and after 10 years 44%. Technique survival was 77%, 65% and 48% respectively. There were 309 episodes of peritonitis as the main complication of treatment (one episode on every 9, 4 months of treatment till 1994 and one episode on every 25, 8 months in the last ten years), out of which 58% was caused by Gram positive bacteria, 18% by Gram negative, 4% were fungal infections while the remaining 20% were culture negative. Regarding other complications we had 42 exit-site infections and 8 episodes of sclerosing peritonitis with 4 deaths. We found peritonitis to be the main reason of switching to haemodialysis (71%) and the main reason of death (39%) among the patients on CAPD. In the last 10 years (1997-2007) we analyzed the diabetics group separately and we found that the rate of CAPD dropout was not significantly different between diabetics and non-diabetics group. However, when analysing the causes of CAPD dropout, we found significant difference in mortality ate (50% among diabetics versus 26% among non-diabetics) and the rate of switching to haemodialysis (37% versus 55% respectively). In addition we established that the rate of CAPD survival was better after 1994 and we speculate that the main reason is the diminished peritonitis rate.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[腹膜透析治疗的长期结果——27年单中心经验]。
到2007年底,我们中心有160名患者接受CAPD治疗(男性44%,女性56%),年龄在29-78岁之间。到1994年,我们13%的病人是糖尿病患者。在过去10年(1997-2007)中,糖尿病患者的比例增加到36%。在27年期间,44%的患者死亡,35%改用血液透析,3%接受肾移植。3年生存率为75%,5年生存率为63%,10年生存率为44%。技术生存率分别为77%、65%和48%。治疗的主要并发症有309例腹膜炎(至1994年每9.4个月1例,近10年每25.8个月1例),其中革兰氏阳性菌占58%,革兰氏阴性菌占18%,真菌感染占4%,培养阴性菌占20%。至于其他并发症,我们有42例出口部位感染和8例硬化性腹膜炎,其中4例死亡。我们发现腹膜炎是CAPD患者转向血液透析的主要原因(71%)和死亡的主要原因(39%)。在最近10年(1997-2007)中,我们对糖尿病组进行了单独分析,我们发现糖尿病组和非糖尿病组的CAPD辍学率没有显著差异。然而,当分析CAPD退出的原因时,我们发现死亡率(糖尿病患者为50%,非糖尿病患者为26%)和转向血液透析的比率(分别为37%和55%)存在显著差异。另外,我们发现1994年以后CAPD的生存率有所提高,推测其主要原因是腹膜炎发生率的降低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta Medica Croatica
Acta Medica Croatica Medicine-Medicine (all)
自引率
0.00%
发文量
0
期刊介绍: ACTA MEDICA CROATICA publishes original contributions to medical sciences, that have not been previously published. All manuscripts should be written in English.
期刊最新文献
[DWI MAGNETIC RESONANCE IN CHARACTERIZATION OF FOCAL LIVER LESIONS]. [RARE LOCALIZATION OF OSTEOID OSTEOMA--DISTAL PHALANX OF THE RING FINGER]. [SURGICAL TREATMENT OF THYROID GLAND IN ELDERLY PATIENTS: OUR EXPERIENCES]. [ACUTE PAIN MANAGEMENT IN PATIENT ON OPIOID SUBSTITUTION THERAPY WITH METHADONE OR BUPRENORPHINE]. [Letter].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1